Taglich Brothers Expects Weaker Earnings for Cosmos Health

Cosmos Health Inc. (NASDAQ:COSM) – Investment analysts at Taglich Brothers cut their Q3 2025 EPS estimates for shares of Cosmos Health in a report issued on Monday, November 25th. Taglich Brothers analyst H. Halpern now anticipates that the company will post earnings of ($0.01) per share for the quarter, down from their previous estimate of $0.03. The consensus estimate for Cosmos Health’s current full-year earnings is ($0.48) per share. Taglich Brothers also issued estimates for Cosmos Health’s Q4 2025 earnings at $0.04 EPS.

Cosmos Health Trading Up 3.2 %

COSM opened at $0.81 on Wednesday. The stock has a market capitalization of $18.91 million, a P/E ratio of -0.32 and a beta of 5.72. Cosmos Health has a 12 month low of $0.47 and a 12 month high of $1.65. The firm’s fifty day simple moving average is $0.78 and its 200 day simple moving average is $0.91. The company has a current ratio of 1.44, a quick ratio of 1.24 and a debt-to-equity ratio of 0.08.

Cosmos Health Company Profile

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names.